business
Why doctors stood up and cheered mid-presentation for a historic pancreatic cancer treatment
The announcement of a successful late-stage treatment that nearly doubles the survival for patients with deadly pancreatic cancer brought an audience of doctors and other global oncology professions to their feet on Sunday.
Read full story on MarketWatch → More top storiesAlso covered by
NPR News
Experimental pill promises new hope for deadly pancreatic cancer
Mail & Guardian
Indigenous plant study opens new path in cancer treatment research
BBC News
Daily pill doubles survival time for pancreatic cancer patients
Investing.com
Revolution Medicines reports phase 3 pancreatic cancer trial results
Aggregated and edited by the Scoop newsroom. We surface news from MarketWatch alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop